Cargando…

Nonergot dopamine-receptor agonists for treating Parkinson’s disease – a network meta-analysis

OBJECTIVE: To compare the efficacy of the three nonergot dopamine-receptor agonists (DAs) pramipexole, ropinirole, and rotigotine for the treatment of early and advanced Parkinson’s disease (PD). MATERIALS AND METHODS: Bayesian network meta-analyses were performed separately for early and advanced P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thorlund, Kristian, Wu, Ping, Druyts, Eric, Eapen, Shawn, Mills, Edward J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019622/ https://www.ncbi.nlm.nih.gov/pubmed/24855362 http://dx.doi.org/10.2147/NDT.S60061

Ejemplares similares

The risk of elevated prolactin levels in pediatric patients exposed to antipsychotics for the treatment of schizophrenia and schizophrenia spectrum disorders: protocol for a systematic review and meta-analysis
por: Druyts, Eric, et al.
Publicado: (2014)

SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin
por: Thorlund, Kristian, et al.
Publicado: (2014)

Incorporating alternative design clinical trials in network meta-analyses
por: Thorlund, Kristian, et al.
Publicado: (2014)

Use of network meta-analysis in clinical guidelines
por: Kanters, Steve, et al.
Publicado: (2016)

The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of pharmacotherapies for moderate to severe COPD
por: Thorlund, Kristian, et al.
Publicado: (2014)

Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis
por: Thorlund, Kristian, et al.
Publicado: (2012)

Interpreting discordant indirect and multiple treatment comparison meta-analyses: an evaluation of direct acting antivirals for chronic hepatitis C infection
por: Druyts, Eric, et al.
Publicado: (2013)

Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection
por: Thorlund, Kristian, et al.
Publicado: (2012)

Sample size and power considerations in network meta-analysis
por: Thorlund, Kristian, et al.
Publicado: (2012)

Hypoglycemia: a review of definitions used in clinical trials evaluating antihyperglycemic drugs for diabetes
por: Balijepalli, Chakrapani, et al.
Publicado: (2017)

Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis
por: Balijepalli, Chakrapani, et al.
Publicado: (2018)

Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis
por: Cooper, Curtis L, et al.
Publicado: (2012)

Prolactin-related adverse events and change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: A systematic review
por: Druyts, Eric, et al.
Publicado: (2016)

The treatment of Parkinson's disease with dopamine agonists
por: Konta, Brigitte, et al.
Publicado: (2008)

Efficacy and safety of non‐ergot dopamine‐receptor agonists as an adjunct to levodopa in advanced Parkinson's disease: A network meta‐analysis
por: Chen, Xiang‐Ting, et al.
Publicado: (2022)

Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists
por: Mohammad, Mohammad Edrees, et al.
Publicado: (2021)

Stability of additive treatment effects in multiple treatment comparison meta-analysis: a simulation study
por: Thorlund, Kristian, et al.
Publicado: (2012)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009)

Comparative efficacy and safety of six non-ergot dopamine-receptor agonists in early Parkinson's disease: a systematic review and network meta-analysis
por: Chen, Xiang-Ting, et al.
Publicado: (2023)

Dopamine agonist monotherapy utilization in patients with Parkinson’s disease
por: Frazer, Monica, et al.
Publicado: (2022)

Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals
por: Thorlund, Kristian, et al.
Publicado: (2010)

Modelling heterogeneity variances in multiple treatment comparison meta-analysis – Are informative priors the better solution?
por: Thorlund, Kristian, et al.
Publicado: (2013)

Causes and factors related to dopamine agonist withdrawal in Parkinson′s disease
por: Castro, Ester Suárez, et al.
Publicado: (2016)

Chronic exposure to dopamine agonists affects the integrity of striatal D(2) receptors in Parkinson's patients
por: Politis, Marios, et al.
Publicado: (2017)

The effects of excluding treatments from network meta-analyses: survey
por: Mills, Edward J, et al.
Publicado: (2013)

Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis
por: Cooper, C., et al.
Publicado: (2013)

The effects of dopamine and dopamine receptor agonists on the phototransduction cascade of frog rods
por: Nikolaeva, Darya A., et al.
Publicado: (2019)

Risk of medication overuse headache across classes of treatments for acute migraine
por: Thorlund, Kristian, et al.
Publicado: (2016)

Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment
por: Ersche, Karen D., et al.
Publicado: (2010)

Dopamine Receptors and Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2011)

Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist
por: Zhang, Jinglin, et al.
Publicado: (2016)

Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease
por: Picillo, Marina, et al.
Publicado: (2020)

Dopamine Agonist-Associated Hiccup in Parkinson’s Disease: A Case Report
por: EMEKLİ, Ahmed Serkan, et al.
Publicado: (2019)

Differences in clinical outcomes among hepatitis C genotype 1-infected patients treated with peginterferon alpha-2a or peginterferon alpha-2b plus ribavirin: a meta-analysis
por: Druyts, Eric, et al.
Publicado: (2012)

Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis
por: Mills, Edward J, et al.
Publicado: (2011)

Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment
por: Isaacson, Stuart H., et al.
Publicado: (2023)

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Compulsive Drumming Induced by Dopamine Agonists in Parkinson’s Disease: Another Aspect of Punding
por: Vitale, Carmine, et al.
Publicado: (2013)

No Dopamine Agonist Modulation of Brain [(18)F]FEOBV Binding in Parkinson’s Disease
por: Albin, Roger L., et al.
Publicado: (2022)

Role of dopamine and selective dopamine receptor agonists on mouse ductus arteriosus tone and responsiveness
por: Crockett, Stacey L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_81hibs9lo8rem3c245mejudc06